Relapse-free survival | Breast cancer-specific survival | |||||
---|---|---|---|---|---|---|
Clinical variable | HR | P-value | 95% CI | HR | P-value | 95% CI |
CTC status (†) | 1.8 | 0.043 | 1.0 to 3.3 | 1.9 | 0.032 | 1.1 to 3.6 |
DTC status (†) | * | * | * | * | * | * |
Lymph nodes (vs pN0) | < 0.001 | < 0.001 | ||||
- pN1 | 2.2 | 0.001 | 1.4 to 3.5 | 2.6 | 0.001 | 1.5 to 4.5 |
- pN2/3 | 3.2 | < 0.001 | 1.8 to 5.5 | 3.8 | < 0.001 | 2.1 to 7.0 |
Histological grade (vs I) | 0.053 | 0.049 | ||||
- grade II | 2.0 | 0.094 | 0.9 to 4.5 | 1.6 | 0.324 | 0.6 to 4.3 |
- grade III | 2.8 | 0.019 | 1.2 to 6.8 | 2.8 | 0.044 | 1.0 to 7.7 |
Tumour size (< 20 mm vs > 20 mm) | 1.9 | 0.002 | 1.3 to 2.9 | 2.4 | < 0.001 | 1.5 to 3.8 |
ER/PR status (‡) | 1.7 | 0.028 | 1.1 to 2.7 | 1.9 | 0.018 | 1.1 to 3.1 |
HER2 status (†) | * | * | * | 1.8 | 0.024 | 1.1 to 3.1 |
Vascular Invasion (†) | 1.6 | 0.048 | 1.0 to 2.5 | 1.8 | 0.015 | 1.1 to 3.0 |